Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 3 to 8

Wearable technology to improve upper limb function in children with unilateral cerebral palsy

Official title: Innovative Use of Wereable Technology for Improving Functionality in Children with Unilateral Cerebral Palsy

Run by Universidade da Coruña · NCT06872736 · Data updated 2026-11-12

This study is testing a wearable device to see if it can help young children with unilateral cerebral palsy use their affected arm better in daily activities.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages3 Years to 8 Years
SexAll
Enrollment40 (estimated)
SponsorUniversidade da Coruña
Academic / other
Locations1 site (A Coruña, A Coruña)
StatusRecruiting
StartedJune 7, 2024
Main results expectedSeptember 14, 2024
Study endsDecember 20, 2026
Registry record updatedMarch 12, 2025
Trial IDNCT06872736 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 8 years with a confirmed diagnosis of unilateral cerebral palsy and classified as levels I to III on the Manual Ability Classification System.

Probably not a fit

Patients who have had recent botulinum toxin injections or surgical interventions in the upper limb, or those with uncontrolled medical complications, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This national interventional study aims to evaluate the effectiveness of a wearable device, WeFun, designed to enhance the functionality of the affected upper limb in children with unilateral cerebral palsy (UCP). The study focuses on children aged 3 to 8 years who are classified as levels I to III on the Manual Ability Classification System. Participants will engage in home-based training that incorporates the wearable technology to assess and improve their upper limb movement and daily living activities. The goal is to increase the spontaneous use of the affected limb, thereby enhancing overall participation and quality of life.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the independence and quality of life for children with unilateral cerebral palsy.

How similar studies have gone: Other studies utilizing wearable technology for rehabilitation in similar populations have shown promising results, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed diagnosis of UCP.
* Children aged between 3 and 8 years old.
* Children rated on levels I to III on the Manual Ability Classification System (MACS).

Exclusion Criteria:

* Botulinum toxin injection or surgical interventions in the upper limb within 6 months prior to study entry.
* Medical complications non-controlled that would interfere with study participation (e.g., not controlled epilepsy).
* Predominantly athetoid or dystonia movement patterns.
* Insufficient cognitive level to follow instructions,
* Non-corrected marked visual impairments.

Families can be retired from the study after starting if:

* Families don't assist or don't collaborate in the weekly sessions with the reference person.
* Wearable activity if presumably lower than expected (few recordings of activity, \<20%).
* Families don't provide feedback about daily sessions through the satisfaction system in the app/registration sheet.

Where it's running

  • Universidade da Coruña
    A Coruña, A Coruña, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.